The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

Shanghai scientists have made breakthrough in protein design by leveraging artificial intelligence, establishing the world's ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by ...

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...

The following is a summary of “Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1,” published in the March 2025 issue of ...

The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...

A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...

Companies from these countries collectively account for 19 out of 28 assets worldwide. South Korea and China are leading in ...

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile VANCOUVER, British Columbia, March 25, 2025 (GLOBE ...